Market Access at eyeforpharma

Memo

Key Themes Explored in 2019 Build the market access ecosystem:Foster genuine payment innovation with stakeholder collaboration to match rapidly increasing treatment effectiveness Access at Day 1:Make market access a company-wide imperative, from the start of development through commercialisation Translate patient to payer value:Find KPIs which justify pricing models through measuring real patient journeys Big data, bigger opportunity:Ensure real-world evidence meets payer standards to guarantee decision-making impact The event will be driven by pharma senior executives and key stakeholders across the industry, including: • Martin Price, VP, HEOR, Market Access and Reimbursement, Janssen• Daniel Jackson, Global Head, Market Access Solutions and Strategy, UCB • Gillian Leng, Deputy Chief Executive Officer, NICE • Giuseppe Rosano, Member CVWP, European Medicines Agency, Consultant Cardiologist, Agenzia Italiana del Farmaco• Ruediger Papsch, Senior Director, Global Head Market Access and Pricing Fertility, Merck KGaA URL:Tickets: https://go.evvnt.com/282553-1?pid=5569 Time: 8:00 am - 3:00 pm  Venue Details: Centre de Convencions Internacional de Barcelona, 11-14 Placa de Willy Brandt, Barcelona, 08019, Spain